NSE IPO - Apply Online, Check Issue Date, Price, Lot Size & Allotment Status

Apply for NSE IPO:

Skip to main content

Live Phio Pharmaceuticals Corp. Common Stock Share Price Chart

O H L

Phio Pharmaceuticals Corp. Common Stock Performance Overview

Days Range
$1.03Low
$1.03High

Markets Today

Previous Close$1.02
Open$1.03
Volume13,998
Day's Range$1.03 - $1.03
52W Range$0.81 - $4.19
Market Cap$11.61 M

Historical Performance

1M Returns-2.86
3M Returns-0.97
6M Returns-15.00
1Y Returns-51.66
5Y Returns-99.59
10Y ReturnsNA

Phio Pharmaceuticals Corp. Common Stock Fundamentals

Market Cap$11.61 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTM-0.70
EPS TTM$-1.39
Quarterly Earnings Growth YOYN/A
PB Ratio0.92
EBITDA$-9.22 M
Profit MarginN/A
Market Cap$11.61 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTM-0.70
EPS TTM$-1.39
Quarterly Earnings Growth YOYN/A
PB Ratio0.92
EBITDA$-9.22 M
Profit MarginN/A

Phio Pharmaceuticals Corp. Common Stock Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$0$0$0$0$0$0
Gross Profit +$0$0$0$0$0$0
Operating Income -$1.87 M-$2.31 M-$2.50 M-$2.53 M-$4.17 M-$4.27 M
EBITDA -$1.87 M-$2.31 M-$2.50 M-$2.53 M-$4.17 M-$4.27 M
Interest Expense $0$0$0$0$0$0
Depreciation $0$0$2.00 K$1.00 K$1.00 K$1.00 K
Income Before Tax -$1.77 M-$2.17 M-$2.39 M-$2.37 M-$4.00 M-$4.14 M
Income Tax Expense $0$0$0$0$0$0
Net Income +-$1.77 M-$2.17 M-$2.39 M-$2.37 M-$4.00 M-$4.14 M
Net Profit Margin ------

Phio Pharmaceuticals Corp. Common Stock Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $0$0$1.00 K$1.00 K$1.00 K$1.00 K
Reserve & Surplus -$148.13 M-$150.29 M-$152.68 M-$155.05 M-$159.06 M-$163.19 M
Non-Current Liabilities $0$0$0$0$0$0
Current Liabilities $1.27 M$1.21 M$1.67 M$1.34 M$950.00 K$1.71 M
Total Liabilities $1.27 M$1.21 M$1.67 M$1.34 M$950.00 K$1.71 M
Fixed Assets $4.00 K$7.00 K$12.00 K$11.00 K$10.00 K$9.00 K
Current Assets $13.44 M$11.29 M$11.49 M$21.48 M$17.40 M$14.30 M
Total Assets $13.44 M$11.30 M$11.51 M$21.49 M$17.41 M$14.31 M

Phio Pharmaceuticals Corp. Common Stock Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income -$1.77 M-$2.17 M-$2.39 M-$2.37 M-$4.00 M-$4.14 M
Operating Cash Flow -$1.27 M-$2.54 M-$2.08 M-$2.08 M-$4.00 M-$4.04 M
Investing Cash Flow -$2.00 K-$3.00 K-$7.00 K$0$3.00 K$0
Financing Cash Flow $9.17 M$40.00 K$2.02 M$12.40 M$0$0
Change in Cash $7.90 M-$2.50 M-$70.00 K$10.33 M-$4.00 M-$4.04 M

Phio Pharmaceuticals Corp. Common Stock Return Calculator

The Phio Pharmaceuticals Corp. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$41
Invested Amount$10,000
Est. Returns$-9,959
Invest in USA Stock Today

About Phio Pharmaceuticals Corp. Common Stock

Phio Pharmaceuticals Corp is a clinical-stage biopharmaceutical company whose proprietary INTASYL small-interfering RNA gene silencing technology is designed to make immune cells more effective in killing tumor cells. Its pipeline programs are PH-762 and PH-894. The group is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems. It is committed to discovering and developing cancer treatments for patients by creating new pathways toward a cancer-free future. The Company operates with a single operating segment, the Clinical segment, and all assets are located in the United States.

FAQs

Phio Pharmaceuticals Corp. Common Stock (PHIO) share price as of September 18, 2026 is $1.01. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Phio Pharmaceuticals Corp. Common Stock (PHIO) Share by opening an international trading account with Angel One.
Purchasing Phio Pharmaceuticals Corp. Common Stock (PHIO) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Phio Pharmaceuticals Corp. Common Stock (PHIO) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Phio Pharmaceuticals Corp. Common Stock (PHIO) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Phio Pharmaceuticals Corp. Common Stock on September 18, 2026, is $11.61 M.
Phio Pharmaceuticals Corp. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in Phio Pharmaceuticals Corp. Common Stock (PHIO) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91